Bubble in IPOs – Is there an upside to CarGurus?
CarGurus operates a popular online platform to connect sellers and buyers of new and used cars. Its revenues grew by 100% in 2016 and 70% in the first half of 2017. Growth was supported by…
Hamilton Beach Holdings – A great Company at fair value
It’s hard to understand the logic of combining a coal mining company with an electric household appliance company, and that’s probably why NACCO Industries (NC) has recently separated Hamilton Beach Holdings (HBB) through a spin-off….
Not bubbly but expensive – Time to exit the Stock Market?
The stock market continues to climb and break records. Since the beginning of the year, US indices have already yielded double-digit returns (my spin-off portfolio in this site is already up 21.5% YTD). Even the…
JBG Smith Properties – Is this great Spin-off REIT an attractive buy?
Summary JBG Smith is a $4.8 Billion spin-off of Vornado Realty Trust Washington, DC properties that merged with JBG Companies assets. It has a rich portfolio of offices, residential and commercial buildings with more than…
How to Invest Like Benjamin Graham and Warren Buffet
Benjamin Graham, who is considered to be the father of value investing, never pretended to help investors get rich. His main aim was to help them achieve reasonable returns on their investments. In practice, some…
BNED is down sharply. Buy more?
This is already a regular ritual – BNED publishes reasonable annual (or quarterly) results, but the stock actually crashes 11% two days in a row. What’s interesting is that yesterday the stock opened up more…
New Service: Upcoming Spin-offs
In 2008 Mohnish Pabrai and Guy Spier paid $650,100 to eat lunch with Warren Buffet and Charlie Munger, where among other things Charlie recommended that they should “carefully study spinoffs”. He knows what he is…
Launching of the Premium Membership plan
Dear Subscribers, The SpinOff list has been in beta for quite some time now, during this period we provided all of our Free Update members access to the portfolio, free of charge. We hope you…
Actelion shareholders approve J&J takeover and Idorsia spin-off
The shareholders of the Swiss biotech company Actelion approved the acquisition by Johnson & Johnson (JNJ). As a reminder, J&J offered to buy Actelion for $30 billion, and now the acquisition could be completed by…
Is Bioverativ (BIVV) cheap enough?
Bioverativ (BIVV),the Hematology Division of Biogen, has recently separated from the pharmaceutical giant, mainly to let it continue its strong growth on its own. BIVV concentrates on hemophilia, a market whose size is estimated at…